Chile Siachisumo
Dr Sara Luzzi
Saad Aldalaqan
Dr Gerald Hysenaj
Caroline Dalgliesh
et al. | An anciently diverged family of RNA binding proteins maintain correct splicing of a class of ultra-long exons through cryptic splice site repression | 2024 |
|
Dr Kirsty Hodgson
Maggie Orozco Moreno
Emily Archer Goode
Dr Rebecca Garnham
Karen Livermore
et al. | Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone | 2024 |
|
Maggie Orozco Moreno
Dr Kirsty Hodgson
Amirah Nabilah
Meera Murali
Jess Peng
et al. | Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells | 2024 |
|
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al. | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer | 2024 |
|
Rahul Advani
Dr Sara Luzzi
Dr Emma Scott
Caroline Dalgliesh
Dr Jennifer Munkley
et al. | Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer | 2023 |
|
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al. | ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer | 2023 |
|
Dr Emma Scott
Emily Archer Goode
Rebecca Garnham
Dr Kirsty Hodgson
Maggie Orozco Moreno
et al. | ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression | 2023 |
|
Maggie Orozco Moreno
Dr Kirsty Hodgson
Kayla Bastian
Emily Archer Goode
Dr Jennifer Munkley
et al. | Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors | 2023 |
|
Dr Kirsty Hodgson
Maggie Orozco Moreno
Dr Emma Scott
Rebecca Garnham
Karen Livermore
et al. | The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer | 2023 |
|
Dr Emma Scott
Dr Kirsty Hodgson
Kat Cheung
Edward Yo
Laura Wilson
et al. | Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth | 2023 |
|
Dr Jennifer Munkley
| Aberrant Sialylation in Cancer: Therapeutic Opportunities | 2022 |
|
Adam Duxfield
Dr Jennifer Munkley
Professor Michael Briggs
Dr Ella Dennis
| CRELD2 is a novel modulator of calcium release and calcineurin-NFAT signalling during osteoclast differentiation | 2022 |
|
Dr Emma Scott
Rebecca Garnham
Adam Duxfield
Professor David Elliott
Dr Jennifer Munkley
et al. | Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate Cancer | 2022 |
|
Kayla Bastian
Dr Emma Scott
Professor David Elliott
Dr Jennifer Munkley
| Fut8 alpha-(1,6)-fucosyltransferase in cancer | 2021 |
|
Dr Emma Scott
Professor David Elliott
Dr Jennifer Munkley
| Tumour associated glycans: A route to boost immunotherapy? | 2020 |
|
Alice Coomer
Dr Fiona Black
Professor Alastair Greystoke
Dr Jennifer Munkley
Professor David Elliott
et al. | Alternative splicing in lung cancer | 2019 |
|
Dr Jennifer Munkley
SR Gokul Krishnan
Gerald Hysenaj
Dr Emma Scott
Caroline Dalgliesh
et al. | Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer | 2019 |
|
Emma Scott
Dr Jennifer Munkley
| Glycans as Biomarkers in Prostate Cancer | 2019 |
|
Rebecca Garnham
Dr Emma Scott
Karen Livermore
Dr Jennifer Munkley
| ST6GAL1: A key player in cancer (Review) | 2019 |
|
Dr Jennifer Munkley
Dr Emma Scott
| Targeting Aberrant Sialylation to Treat Cancer | 2019 |
|
Dr Jennifer Munkley
| The glycosylation landscape of pancreatic cancer | 2019 |
|
Dr Jennifer Munkley
Karen Livermore
Dr Ingrid Ehrmann
Dr Katherine James
Dr Prabhakar Rajan
et al. | Androgen-dependent alternative mRNA isoform expression in prostate cancer cells | 2018 |
|
Dr Jennifer Munkley
| Glycosylation is a global target for androgen control in prostate cancer cells | 2017 |
|
Dr Jennifer Munkley
Karen Livermore
Dr Prabhakar Rajan
Professor David Elliott
| RNA splicing and splicing regulator changes in prostate cancer pathology | 2017 |
|
Dr Jennifer Munkley
Dr Urszula McClurg
Karen Livermore
Dr Ingrid Ehrmann
Professor Craig Robson
et al. | The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration | 2017 |
|
Karen Livermore
Dr Jennifer Munkley
Professor David Elliott
| Androgen receptor in prostate cancer | 2016 |
|
Dr Jennifer Munkley
Karen Livermore
Dr Katherine James
Dr Brian Wilson
Professor Craig Robson
et al. | Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability | 2016 |
|
Dr Jennifer Munkley
Professor David Elliott
| Hallmarks of glycosylation in cancer | 2016 |
|
Dr Irina Neganova
Dr Evgeniya Shmeleva
Dr Jennifer Munkley
Dr Valeria Chichagova
Dr George Anyfantis
et al. | JNK/SAPK signalling is essential for efficient reprogramming of human fibroblasts to induced pluripotent stem cells | 2016 |
|
Dr Jennifer Munkley
Professor David Elliott
| Sugars and cell adhesion: the role of ST6GalNAc1 in prostate cancer progression | 2016 |
|
Dr Jennifer Munkley
Professor David Elliott
| The role of glycans in the development and progression of prostate cancer | 2016 |
|
Dr Jennifer Munkley
| The Role of Sialyl-Tn in Cancer | 2016 |
|
Dr Jennifer Munkley
Professor Craig Robson
Professor Hing Leung
Dr Prabhakar Rajan
Professor David Elliott
et al. | Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer | 2015 |
|
Dr Brian Wilson
Dr Jennifer Munkley
| Metronidazole Toxicity in Cockayne Syndrome: A Case Series | 2015 |
|
Dr Jennifer Munkley
Dr Brian Wilson
Karen Livermore
Dr Vasileios Floros
Professor Craig Robson
et al. | The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer | 2015 |
|
Dr Jennifer Munkley
Karen Livermore
Dr Urszula McClurg
Professor Craig Robson
Dr Prabhakar Rajan
et al. | The PI3K regulatory subunit gene PIK3R1 is under direct control of androgens and repressed in prostate cancer cells | 2015 |
|
Dr Veronika Boczonadi
Dr Juliane Mueller
Dr Angela Pyle
Dr Jennifer Munkley
Michele Giunta
et al. | EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia | 2014 |
|
Dr Jennifer Munkley
Dr Prabhakar Rajan
Caroline Dalgliesh
Robert Jackson
Professor Craig Robson
et al. | A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation | 2014 |
|
